Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Rectal Neoplasms 29Esophageal Neoplasms 18Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Non-Small-Cell Lung 14Nasopharyngeal Carcinoma 12Uterine Cervical Neoplasms 11Head and Neck Neoplasms 11Pancreatic Neoplasms 8Oropharyngeal Neoplasms 8Lung Neoplasms 6Glioblastoma 6Carcinoma, Squamous Cell 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Mouth Neoplasms 4Hypopharyngeal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Adenocarcinoma 4Radiation Injuries 3Pathologic Complete Response 3Carcinoma 3Breast Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms 2Nasopharyngeal Neoplasms 2NSCLC 2Lymphoma 2Lymphatic Metastasis 2

Interventions

Cisplatin 2Standard of Care 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Erlotinib Hydrochloride 1Docetaxel 1Chemoradiotherapy 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Tonsillar Neoplasms × Chemoradiotherapy × Clear all
NCT00140556 2013-01-18

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Duke University

Phase EARLY_PHASE1 Completed
28 enrolled 8 charts
Head & Neck

Head and Neck Neoplasms, Pharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡